Free Trial

Quantinuum (NASDAQ:QNT) Price Target Cut to $55.00 by Analysts at Cantor Fitzgerald

Quantinuum logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Cantor Fitzgerald cut Quantinuum’s price target to $55 from $90 but maintained an “overweight” rating; the new target implies 84.44% upside from the previous close.
  • Analyst sentiment remains broadly positive: Quantinuum has a “Moderate Buy” consensus rating and an average price target of $88.46.
  • Quantinuum reported a quarterly loss of $0.29 per share, narrower than the expected $0.99 loss, on revenue of $9.05 million; the company also raised its FY2026 revenue outlook.
  • Five stocks to consider instead of Quantinuum.

Quantinuum (NASDAQ:QNT - Get Free Report) had its price objective lowered by equities researchers at Cantor Fitzgerald from $90.00 to $55.00 in a report released on Friday, Benzinga reports. The firm currently has an "overweight" rating on the stock. Cantor Fitzgerald's price target indicates a potential upside of 84.44% from the stock's previous close.

QNT has been the topic of several other reports. Jefferies Financial Group set a $85.00 price target on shares of Quantinuum in a report on Wednesday, August 12th. Rosenblatt Securities reaffirmed a "buy" rating and set a $155.00 target price on shares of Quantinuum in a research report on Thursday, October 22nd. Needham & Company LLC restated a "buy" rating and issued a $100.00 price target on shares of Quantinuum in a research report on Wednesday, August 12th. Yorkville Ives started coverage on shares of Quantinuum in a research report on Monday, October 5th. They set an "outperform" rating and a $60.00 price objective for the company. Finally, Morgan Stanley raised shares of Quantinuum from an "equal weight" rating to an "overweight" rating and lowered their target price for the stock from $78.00 to $62.00 in a research note on Thursday, October 15th. Thirteen research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Quantinuum has an average rating of "Moderate Buy" and an average price target of $88.46.

View Our Latest Report on QNT

Quantinuum Stock Performance

Quantinuum stock opened at $29.82 on Friday. Quantinuum has a 12-month low of $28.31 and a 12-month high of $86.79. The company has a 50-day simple moving average of $43.74. The company has a market capitalization of $7.85 billion and a PE ratio of -106.50.

Quantinuum (NASDAQ:QNT - Get Free Report) last issued its earnings results on Thursday, November 5th. The company reported ($0.29) EPS for the quarter, topping the consensus estimate of ($0.99) by $0.70. The business had revenue of $9.05 million for the quarter. Research analysts forecast that Quantinuum will post -4.76 earnings per share for the current year.

Institutional Investors Weigh In On Quantinuum

Several large investors have recently added to or reduced their stakes in QNT. CoreCap Advisors LLC acquired a new stake in shares of Quantinuum during the 3rd quarter worth approximately $32,000. Fifth Third Bancorp increased its stake in shares of Quantinuum by 1,530.2% in the 3rd quarter. Fifth Third Bancorp now owns 1,027 shares of the company's stock valued at $49,000 after acquiring an additional 964 shares in the last quarter. IFP Advisors Inc boosted its stake in Quantinuum by 1,150.0% during the third quarter. IFP Advisors Inc now owns 1,250 shares of the company's stock worth $60,000 after acquiring an additional 1,150 shares in the last quarter. Steel Grove Capital Advisors LLC boosted its stake in Quantinuum by 25.6% during the third quarter. Steel Grove Capital Advisors LLC now owns 5,992 shares of the company's stock worth $288,000 after acquiring an additional 1,222 shares in the last quarter. Finally, SBI Securities Co. Ltd. grew its holdings in Quantinuum by 52.8% in the third quarter. SBI Securities Co. Ltd. now owns 6,778 shares of the company's stock worth $326,000 after purchasing an additional 2,343 shares during the period.

More Quantinuum News

Here are the key news stories impacting Quantinuum this week:

  • Positive Sentiment: Raised revenue outlook and strong growth: Third-quarter revenue increased 233% year over year, and Quantinuum raised its FY2026 revenue outlook. It also reported a loss of $0.29 per share, narrower than the $0.99 loss analysts expected. Quantinuum Q3 results and outlook
  • Positive Sentiment: Improving commercial traction: The company said platform adoption rose nearly 20% quarter over quarter, job submissions increased tenfold year over year, and it secured its largest cloud agreement to date, alongside a hyperscaler agreement and an Oracle beta launch. Quantinuum Q3 results and outlook
  • Positive Sentiment: Broker sentiment is favorable: Wall Street brokerages collectively rate QNT “Moderate Buy,” which may support investor confidence. Quantinuum analyst rating
  • Neutral Sentiment: Long-term technology roadmap: Quantinuum outlined Nexus, a developer platform intended to connect application development with its hardware, including the Apollo fault-tolerant system planned for 2029. The roadmap offers potential but depends on future execution. Nexus roadmap announcement
  • Negative Sentiment: Losses persist: Despite beating the quarterly EPS estimate, QNT remained unprofitable, reporting a $0.29-per-share loss. Continued losses could weigh on investor sentiment as the company works to scale its business. Quantinuum quarterly earnings report

Quantinuum Company Profile

(Get Free Report)

Quantinuum is a quantum computing company formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum. The company develops full-stack quantum computing technologies designed to support research and commercial applications across industries, including chemistry, materials science, cybersecurity, finance and artificial intelligence.

Its offerings include trapped-ion quantum computers, quantum software and development tools. Quantinuum's software portfolio includes the TKET quantum compiler, InQuanto quantum chemistry platform, Quantum Origin quantum-enhanced cybersecurity solutions and the Nexus platform for developing and managing quantum applications.

Read More

Analyst Recommendations for Quantinuum (NASDAQ:QNT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Quantinuum Right Now?

Before you consider Quantinuum, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantinuum wasn't on the list.

While Quantinuum currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines